Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics
NCT00831961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2015-12-09
Summary
Repeated exposure to topical antibiotics may alter the normal bacteria on the eye and in the nose and increase rates of resistance. This study will determine whether repeated short-term exposure to topical antibiotic drops which are commonly prescribed after eye injections to reduce the chance of infection increase rates of resistant bacteria which are normally found on the eye and in the nose.
We hypothesis that certain commercially available antibiotics may increase rates of bacteria resistance more so than others.
Conditions
- Age-related Macular Degeneration
Interventions
- PROCEDURE
-
Conjunctival and nasopharyngeal bacteria cultures
Conjunctival and nasopharyngeal bacteria cultures
Sponsors & Collaborators
-
Vanderbilt University
lead OTHER
Principal Investigators
-
Stephen J Kim, MD · Vanderbilt University Department of Ophthalmology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2009-11-30
Countries
- United States
Study Locations
More Related Trials
-
Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics
NCT02223338 ·Status: COMPLETED ·Phase: NA
-
A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
NCT03464435 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
NCT00357383 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
NCT00578955 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
NCT00355459 ·Status: WITHDRAWN ·Phase: NA
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability
NCT03063489 ·Status: COMPLETED ·Phase: PHASE1
-
Ocular Surface Microbiome in Dry Eye Patients
NCT02161341 ·Status: COMPLETED
-
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
NCT03557203 ·Status: UNKNOWN
-
Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis
NCT01408082 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
NCT03230058 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)
NCT05548491 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Antibiotic Prophylaxis for Eyelids
NCT03199911 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
NCT00105534 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
NCT05579730 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
NCT05514041 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Mu-Drop System for Serum Eye Drops
NCT03539159 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
NCT00266734 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01211951 ·Status: COMPLETED ·Phase: PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2